![PDF) Clinical effectiveness and cost effectiveness of imatinib dose escalation for the treatment of unresectable and/or metastatic gastrointestinal stromal tumors that have progressed on treatment at a dose of 400 mg/day: A PDF) Clinical effectiveness and cost effectiveness of imatinib dose escalation for the treatment of unresectable and/or metastatic gastrointestinal stromal tumors that have progressed on treatment at a dose of 400 mg/day: A](https://i1.rgstatic.net/publication/51234858_Clinical_effectiveness_and_cost_effectiveness_of_imatinib_dose_escalation_for_the_treatment_of_unresectable_andor_metastatic_gastrointestinal_stromal_tumors_that_have_progressed_on_treatment_at_a_dose/links/54379d640cf2027cbb20260b/largepreview.png)
PDF) Clinical effectiveness and cost effectiveness of imatinib dose escalation for the treatment of unresectable and/or metastatic gastrointestinal stromal tumors that have progressed on treatment at a dose of 400 mg/day: A
![Investigation of nonspecific cross-reacting antigen 2 as a prognostic biomarker in bone marrow plasma from colorectal cancer patients | SpringerLink Investigation of nonspecific cross-reacting antigen 2 as a prognostic biomarker in bone marrow plasma from colorectal cancer patients | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs13277-011-0247-5/MediaObjects/13277_2011_247_Fig2_HTML.gif)
Investigation of nonspecific cross-reacting antigen 2 as a prognostic biomarker in bone marrow plasma from colorectal cancer patients | SpringerLink
![PDF) Practice Parameters for the Use of Spinal Cord Stimulation in the Treatment of Chronic Neuropathic Pain PDF) Practice Parameters for the Use of Spinal Cord Stimulation in the Treatment of Chronic Neuropathic Pain](https://i1.rgstatic.net/publication/5850470_Practice_Parameters_for_the_Use_of_Spinal_Cord_Stimulation_in_the_Treatment_of_Chronic_Neuropathic_Pain/links/5d4405324585153e593557c3/largepreview.png)
PDF) Practice Parameters for the Use of Spinal Cord Stimulation in the Treatment of Chronic Neuropathic Pain
![PDF) A study of blood serotonin and serotonin transporter promoter variant (5-HTTLPR) polymorphism in Egyptian autistic children PDF) A study of blood serotonin and serotonin transporter promoter variant (5-HTTLPR) polymorphism in Egyptian autistic children](https://i1.rgstatic.net/publication/276532242_A_study_of_blood_serotonin_and_serotonin_transporter_promoter_variant_5-HTTLPR_polymorphism_in_Egyptian_autistic_children/links/55e399c908ae2fac4721304e/largepreview.png)
PDF) A study of blood serotonin and serotonin transporter promoter variant (5-HTTLPR) polymorphism in Egyptian autistic children
![PDF) Inflammation‐Responsive Hydrogel Spray for Synergistic Prevention of Traumatic Heterotopic Ossification via Dual‐Homeostatic Modulation Strategy PDF) Inflammation‐Responsive Hydrogel Spray for Synergistic Prevention of Traumatic Heterotopic Ossification via Dual‐Homeostatic Modulation Strategy](https://i1.rgstatic.net/publication/373441736_Inflammation-Responsive_Hydrogel_Spray_for_Synergistic_Prevention_of_Traumatic_Heterotopic_Ossification_via_Dual-Homeostatic_Modulation_Strategy/links/64ec8e63434d3f628c54599c/largepreview.png)
PDF) Inflammation‐Responsive Hydrogel Spray for Synergistic Prevention of Traumatic Heterotopic Ossification via Dual‐Homeostatic Modulation Strategy
![NI LABVIEW-Based Breathing Trainer with Biofeedback and Plethysmography | M. Santiago and Mark Angelo C Purio - Academia.edu NI LABVIEW-Based Breathing Trainer with Biofeedback and Plethysmography | M. Santiago and Mark Angelo C Purio - Academia.edu](https://0.academia-photos.com/attachment_thumbnails/43298225/mini_magick20190216-20927-1g75mta.png?1550332226)